Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Operational Feasibility of Appropriate Radical Cure of Plasmodium Vivax With Tafenoquine or Primaquine After Quantitative G6PD Testing in Brazil

NCT05096702 is registered in ClinicalTrials.gov with Fundação de Medicina Tropical Dr. Heitor Vieira Dourado as lead sponsor.

NCT NCT05096702
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05096702 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Operational Feasibility of Appropriate Radical Cure of Plasmodium Vivax With Tafenoquine or Primaquine After Quantitative G6PD Testing in Brazil
Lead sponsor
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado
Phase
Observational
Overall status
Unknown status
Start date
September 9, 2021
Completion date
September 9, 2023
Enrollment
16,000 (actual)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

g6pd deficiency, malaria, vivax